awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36673751-BA0EF90C-D87E-4A3B-ABEA-8B5119BCC42C
Q36673751-BA0EF90C-D87E-4A3B-ABEA-8B5119BCC42C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673751-BA0EF90C-D87E-4A3B-ABEA-8B5119BCC42C
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC.
P2860
Q36673751-BA0EF90C-D87E-4A3B-ABEA-8B5119BCC42C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673751-BA0EF90C-D87E-4A3B-ABEA-8B5119BCC42C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80ea7c2cf7e7344ab33e97426c8f36d9e11982d8
P2860
Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.